Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAND: Extra-fine vs Coarse ICS in Pediatric Asthma
NCT02577497Phase 4Completed
- Sponsor
- University of Virginia
- Start
- Jun 2016
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of beclomethasone and fluticasone in asthma, sponsored by University of Virginia. Primary endpoint: Ventilation Heterogeneity Index at 0 weeks. Started Jun 2016; status: completed.
02
Drugs
beclomethasonefluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02577497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577497.